跳至主要内容
临床试验/CTRI/2026/03/107036
CTRI/2026/03/107036尚未招募不适用

A Randomized, Double-Blind, Placebo-Controlled Subject-Based Clinical Study to Evaluate the Efficacy of Liposomal Collagen (LipoLushTM) Supplementation on Skin Health in Healthy Adults

Botanic Healthcare Pvt. Ltd.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年4月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

Skin ageing and reduction in skin
elasticity are common concerns among adults and may affect overall skin
appearance and quality of life. With increasing age, collagen levels in the
skin gradually decline, leading to wrinkles, reduced firmness, and loss of
elasticity. Oral collagen supplementation is widely used to support skin
structure and improve skin health; however, conventional collagen
formulations may have limited absorption.

Liposomal collagen (LipoLush™) is a novel formulation designed to enhance oral absorption and bioavailability of collagen peptides. This randomized, double-blind, placebo-controlled clinical study aims to evaluate the efficacy and safety of liposomal collagen supplementation compared with placebo in healthy adults.

The study will assess changes in skin elasticity, wrinkle parameters (including wrinkle count, depth, and area), skin hydration, and overall skin appearance. Exploratory assessments will include biochemical markers related to collagen metabolism. Safety will be evaluated through monitoring of adverse events. The study is intended to generate clinical evidence supporting the effectiveness of liposomal collagen supplementation in improving skin health and reducing visible signs of skin ageing in healthy adults.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • 1.Healthy adults aged equal to or more than 18 years.
  • 2.In good general health based on medical history.
  • 3.Visible crow’s feet wrinkles (grade equal to or greater than 2).
  • 4.Willing to avoid other collagen or skin-related supplements during the study.
  • 5.Willing to use only the skincare products provided in the study.
  • 6.Able and willing to provide written informed consent.

排除标准

  • 1.Pregnant or lactating women.
  • 2.Recent facial dermatologic procedures (laser, chemical peel, fillers, botulinum toxin).
  • 3.Active facial skin disorders.
  • 4.Known allergy or hypersensitivity to collagen.
  • 5.Participation in another clinical trial within the past 30 days.
  • 6.Vegan or vegetarian diet restricting animal-derived collagen.

研究者

发起方
Botanic Healthcare Pvt. Ltd.
申办方类型
Other [Herbal Ingredient Manufactures]
责任方
Principal Investigator
主要研究者

Dr Vishal Chakkarwar

InventaLife Research Solutions Pvt. Ltd.

研究点 (1)

Loading locations...

相似试验